Collectively, these have been linked to the progression of CKD and with other key pathogenic proteins, including dipeptidyl peptidase 4 (DPPIV) [95] and vascular endothelial growth factor (VEGF) [96], and have been identified as potential therapeutic targets. This evidence concerns the gene DPP4 and chronic kidney disease.